Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hopefully more between now and ASM. If Charlies on treatment and a plug June 19 from him with Piers Morgan can help more validate the data the journalist are reading. It becomes more than data then..real.
Chump
5TOP- Put a price on a press release from ASM featuring CYDY..well I don't have to tell you the radars we're about to light up on.
And I bet there's more coming.
Chump
Nice! Get the popcorn out!
“We are honored that not only ASM Microbe Conference has accepted our abstract and granted us an oral presentation spot, but has also selected our abstract for an ASM-sponsored press release to highlight our research to the journalists covering this Conference,” said Nader Pourhassan, PhD, the president and CEO of CytoDyn. “We believe that PRO 140 has great potential as an alternative or addition to current standard of care and is currently conducting two phase 3 trials for both of these populations.”
Chump
I put a sticky note on my desk to revisit post# 2459 in a month and a half.
Chump
I don't know what to expect from the abstract today but the mere invitation to present at the ASM will give us national exposure CYDY's been lacking. As well as a peer review on the science.
With this attention and an up list will bring much larger and longer term investors.
Chump
Amatuer- good post. Your last line dilution will continue. I disagree. At this stage and results/data CYDY can easily obtain straight debt no dilution. It's very available with their data. Also BP can provide non dilutive funding for future exclusivity rights. Just as the director ponied up 1 mill. There's plenty of non dilutive money that will be offered to CYDY. There science is for real and smart money will want some. No more of the Paulson etc. deals.
Chump
Explain please why?
Well, anybody have a take on what Monday's abstract will do for us?
Chump
PatrickBateman- I'll be your huckleberry. I agree on the surface..maybe, and Paulson group etc could very easily stall good news. But I betting that CYDY data via ASM etc. takes us over $2.
I hope I'm right.
Chump
misiu143 thank you- You as a physician understand the science data/FDA etc far better than I do. You know it's good. My knack or luck is knowing when someone's got something every bodies gonna want. I remember back in mid 90's qualcomm at $4. Everyday on the silicon investor board techies were going at it. Erickson, Nokia, the leaders at the time hammering Q saying CDMA wasn't plausible. 3-800up and several splits later I was thankful I read some credible posters posts and sat tight. I had a chance at CYDY when it was at high $3's but didn't bite. Been watching ever since. With it's last dip to the low .80's along with the data results made me jump in long and on this board. This board has some extremely good posters on CYDY's science. I appreciate them as I'm new here. Its only a matter of time and when we get off the BB she'll reflect in the SP what's behind it.
Chump
Another comment on "timelines". once again I'll throw out that CYDY is a disruptive science vs whats available now. I have no problem that they hit a hurdle with the FDA. FDA has the elephant on their back to evaluate CYDY.
BTD, per the previous CC isn't an issue. The ASM peer review will cover this. No need to spend the money and reapply. GVHD, once again disruptive. Makes me feel CYDY has the science but the FDA has their protocol.This last CC CYDY says they've assembled a FDA protocol team...great move.
This just appears to be a great new science that the FDA is asking to dot the i's etc.
The delay isn't per the results but FDA protocol. I'm okay with it and mngmt.
Not trying to pump today!
Chump
goldenisla-you're looking at it right, most stocks, but not for a Bio start up. Data is the most important reflecting progress. They all struggle for money in the beginning. Additionally they all face a challenging regimen from the FDA. What makes CYDY/Pro 140 different is the disruptive treatment
they have to offer vs existing. And data supports lower toxicity, quicker lower viral loads and side effects. Sometimes disruptive new treatments get higher scrutiny to ensure it is what it is. CYDY's data supports this. June 20th should align things to any questions on their science. Working for CYDY and against in a favorable way is scientist constantly have to ask why, why... same as physicians do. Not that they're pessimistic but for they are motivated for new changes that better the treatment.
As for revenue this is a multibill arena. Revenue for monotherapy alone. Billions
Hold tight!
Chump
Something that was brought up yesterday and I'll comment again. "Dilution"
This latest at $1-1.35 was a good move by CYDY. The Biggest wow factor was a director took the same offering for 1 mill. That's a very strong message of belief from the inside. Usually they're in for only 50-100k. CYDY has options for funding..now the data is more supportive of their initiatives. With that they could easily ink a deal with BP and funds that gets them through the trials at a min investment to BP but gives exclusivity to the BP if approved. If I was GLD I would ink it. 30-40 mill is a drop for security. Another is straight up funding. I think with the results they will show at the ASM is enough to get debt funding without dilution. Point...funding the trials isn't a foreseeable issue and can be very favorable to shareholders.
IMO-longs should stay in a hold pattern until we breach the $2+ price and decide your exit afterwards given news/data etc. I'm sticking with the long herd.
Chump
Smarter money! Hold pattern for more results.
Chump
Monday can turn this around. The data is good/promising. Director bought 1 mill shares and the actual ASM presentation will bring more exposure. Yes, there's money needed to fund trials but I don't think any additional fundraising will be in the form of dilution. At this point a licensing with GLD exclusively could be an option. What's 20-30 mil from GLD to see it to the finish line.
An easy play for BP.
Chump
I'm convinced this is Paulson group just getting out. The CC didn't cause this.
Chump
Strong msg from mgmnt. "As part of the offering, Jordan G. Naydenov, a director and existing stockholder of the Company, purchased $1.0 million of Common Stock and warrants on terms identical to those applicable to the other investors in the offering."
We might have a wall @ $1.35. Over it and she runs.
Chump
Misiu143- a point..if Dr P was asked about Charlie today and his response was he couldn't comment then that makes me think he's on it. If he wasn't then Dr P could've commented as to no he isn't on CYDY.
Chump
nsomiyak- good point but obviously C wasn't okay with his pill regimen therapy thus he sought out the goat Dr. in Mex. If I was in his shoes and my Dr. gave a thumbs up to CYDY treatment and Charlies Dr has, I would be on it and I think Charlie is. It's a grandstand play but not by CYDY...But by Charlie getting the word out to other HIV carriers...there might be an alternative option vs pill regimen for us.
Chump
misiu143-no, I don't know of any. Piers Morgan for CNN hosts Good Morning Britain. From the articles he appears to be a long friend of Charlies and the interview is supposed to cover C's life after HIV in part. With that I'm certain with C's in and outs with treatment Morgan will ask C what he's doing now and how he feels etc. Just hoping he's on the treatment for the plug for us and other HIV carriers.
Chump
So the next domino to fall is May 16th...ASM abstract. Then anything can come out before the ASM. Charlie and Piers Morgan live interview June 19. Gracious, if he's on treatment and gives a plug will be large. Then the ASM June 20th. I think today was a coming to Jesus meeting that wallstreet needs to hear it's unfolding.
Brett
It was 61k on the bid @ 1.17. I liked it was spread out over 3 different MM's.
Chump
I read the ASM guidance was that a company presenting could give a PR that they were presenting but not release data that is to be for the ASM. 5 days after the ASM then the company can release it.
I could be wrong. Hope I'm wrong.
Chump
gestalt2- 8 years, 1st public offering. Thanks for hanging in there. I know the wait. I'm in another one for 10yrs and waiting. With some good data released we could reach new highs for folks like yourself. Thanks for your support.
Chump
low hanging fruit!!
Fair question. IMO I think the catch is the stock fell below $2 before any significant data was released. This time last year I was watching the stock hadn't bought in and there was days of "0" vol. As the data started coming out so did activity. Unfortunately all under $2. I think there's one insti holding 30k shares. Hopefully between now and July enough news will get it over $2 and some brokers will help it out.
Chump
Very Very Good Bucky!- damn we could use a pr to get this up to an up list price. Just wondering what could come out before the ASM.
Chump
OT-For the Kentucky Derby who here can't root for "suddenbreakingnews"?
C'mon news!!
Chump
The reason I posted it was part of their discussion surrounds Charlie's HIV. The only way we'll know Charlie is on the treatment is if it comes from Charlie. Maybe, and hopefully he'll give a hint of it.
Chump
Looks like Piers Morgan will interview Charlie June 19th. Day before ASM.
http://www.digitalspy.com/showbiz/news/a793194/gmbs-piers-morgan-charlie-sheen-specifically-requested-me-for-his-one-night-only-west-end-show/
Chump
TheBioTechG- Good first post/link! Not just Gilead but every company/analyst/hedge funds etc. that follows events like the ASM Microbe June 20th will be intrigued with CYDY's results not withholding the short time frame they have made such positive progress with the FDA. Many and good irons in the fire....right around the corner!
Welcome.
Chump
d0lphint0m- thanks for taking the time. I haven't immersed myself in charting yet, mostly because there's always someone on my board like yourself that posts it with explanation so well. I learn more from others posts, after collecting information I come to my own conclusions. I looked up scenarios of your yesterdays posts and they say it's followed by an increase in vol and up tick or down tick. I'm hoping we get some good news
and it should go the up tick way to new higher sp and support levels.
Chump
d0lphin0m/etraedge- Is this dip to $1.15 gonna work for us? I appreciate reading the TA's
Chump
Very surprised of the lull in trading today. Expected more active trades and higher vol. Welcome to the OTC. Do expect the GVHD status to have much more upside...when released. R/S, I'm not in favor of but this is an exception. If CYDY has insight of future progress then let's rip the bandaid off and do it. Don't waste these good PR's for the OTC.
R/S do work with positive PR's that follow.
Chump
The FDA uses clinical terminology.... "Break through designation", "Orphan status." for new advances. In technological new advances they use "disruptive" as when we went from the tube to the transistor radio or qualcomm made erickson and nokia bow to them... I listened to the techies on Silicon investor duke it out.. Pictures on our phone now. Thanks to Qualcomm.
Pro140 has this disruptive advantage to change the whole outlook of HIV treatment as well as Gv/hst, cancer and who knows what else. Hold out for more than just Hiv related possibilities.
This is disruptive. Very.
Chump
Thanks Amatuer17. The last thing I wanted to do was start an us vs them argument on this thread. It was only in support of what was posted from someone by IR. Meaning, there are results/data out there CURRENT that support Pro140 as a more realistic/compassionate treatment, less side effects ect. There's been a lot of positive protocols for helping with HIV treatment. They all need applauded. But, since 2010 and now more currently CYDY's results have far exceeded others approach. Hopefully at the ASM we all will get the data/peer reviewed that shows Pro 140's results in comparison to others only in the effort to treat those infected. It's all about the patient.
I feel pro140 is a disruptive new science for HIV and a game changer. For whatever reason you invest.
Chump
Ibalizumab/Pro140 .. This was published July 2015 and cited results from 2010. Page 16 Monoclonal Antibodies references both. Evidently since July 2015 Pro140's result have
been stellar. Also, below that Conclusions, Recommendations. Gilead needs to rethink their HIV pipeline. Also googling Ibalizmumab Pro140 gives many abstract links.
http://i-base.info/htb/wp-content/uploads/2015/07/2015-pipeline-report-web.pdf
Chump
At this price a buy/steal. With no institutional owners an up list will be low hanging fruit to any buys beforehand. I expect higher trade blocks, vol, and move up in price before up list/ ASM. There was a nice 116k block buy Friday at 1.18. The buyers are here just need the sellers to dry up.
Outside of company PR's..if C. Sheen was to go back on the OZ and say his viral loads were down, he felt great, so many irons in the fire for this to
organically get above $2. All the makings for a profitable ride up!
Chump
TitanV- the link should be a sticky.
Chump
A PR follow up to below is what I expect to up list CYDY off the BB.
http://www.cytodyn.com/media/press-releases/detail/219/cytodyn-files-for-orphan-drug-designation-for-use-of-pro
The Company has selected a transplantation indication called GvHD as its first non-HIV clinical indication. The CCR5 receptor, the target for PRO 140, is an important mediator of GvHD, especially in the organ damage that is the usual cause of death. The only approved CCR5 inhibitor, Maraviroc, is currently in a Phase 2 study in GvHD. The Company believes that PRO 140 has significant advantages over Maraviroc in more favorable dosing and pharmacokinetics, less toxicity and side effects, and no direct stimulation (agonist activity) of the CCR5 receptor.
They are well past 100 days!!
Chump